While some chromosomal changes (e.g., chromosomes 1, 10, 17, and 22) and genetic mutations (e.g., MMP25, MMP9, NFKBIA, and DMBT1) are characteristic of several types of brain tumors, detecting changes specific to certain tumors (e.g., the formation of isochromosome 17q in medulloblastoma) is crucial for prognosis and therapy effectiveness. This evidence concerns the gene DMBT1 and brain neoplasm.